SAN JOSE, Calif. and HYDERABAD, India, June 12, 2025 /PRNewswire/ -- Cyient Semiconductors Private Limited, a fast-growing custom silicon company…
MCLEAN, Va.--(BUSINESS WIRE)--#NSTA--The National Science Teaching Association (NSTA) today announced the newest members of its Board of Directors, as well…
MILAN, Italy, June 06, 2025 – Italfarmaco S.p.A. announced today that the European Commission (EC) has granted conditional marketing authorisation…
LOS ANGELES, June 05, 2025 (GLOBE NEWSWIRE) -- ServiceTitan (NASDAQ: TTAN), the software platform that powers the trades, today announced…
46% reduction in the risk of disease progression or death, and 27% reduction in the risk of death, in an…
Treatment with casdatifan, a HIF-2a inhibitor, plus cabozantinib, a tyrosine kinase inhibitor, showed a confirmed overall response rate (ORR) of…
The ItovebiTM (inavolisib)-based regimen reduced the risk of death by more than 30% in people with PIK3CA-mutated HR-positive, HER2-negative advanced…